Article
Differential susceptibility and role for senescence in CART cells based on costimulatory domains
10 Jun 2025
Abstract excerpt
Despite the success of chimeric antigen receptor T (CART) cell therapy in hematological malignancies, durable remissions remain low. Here, we report CART senescence as a potential resistance mechanism in 41BB-costimulated CART cell therapy. To mimic cancer relapse, we utilized an in vitro model with repeated CART cell activation cycles followed by rest periods. Using CD19-targeted CART cells with costimulation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
